Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus

Immunosuppression is a known risk factor for cervical cancer. Women with rheumatic conditions are immunosuppressed due to the disease and the treatments. One of the main risk factors for this neoplasm is the lack of adherence to early detection programmes for human papillomavirus. The objectives of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Reumatología clinica (Barcelona) 2021-11, Vol.17 (9), p.494-498
Hauptverfasser: Vidal Alejandre, Blanca, Tovar Sugrañes, Ernesto, López Poza, Raquel, Andrés, Mariano, Martínez-Vidal, María Paz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 498
container_issue 9
container_start_page 494
container_title Reumatología clinica (Barcelona)
container_volume 17
creator Vidal Alejandre, Blanca
Tovar Sugrañes, Ernesto
López Poza, Raquel
Andrés, Mariano
Martínez-Vidal, María Paz
description Immunosuppression is a known risk factor for cervical cancer. Women with rheumatic conditions are immunosuppressed due to the disease and the treatments. One of the main risk factors for this neoplasm is the lack of adherence to early detection programmes for human papillomavirus. The objectives of this study were to evaluate the adherence to the screening programme of patients in the Rheumatology Clinic, as well as to evaluate the prevalence of cervical lesions and their association with the different disease characteristics and the treatments received. A descriptive retrospective study. The electronic medical history of patients actively being followed up in a tertiary hospital with rheumatoid arthritis (RA), psoriatic arthritis (PSA) and systemic lupus erythematosus (SLE) were reviewed. Finally, 307 patients were included. No data were found for screening programme attendance in up to 42.4% of the patients (39.6% in RA, 43.8% in PSA and 46% in SLE). Among the patients who attended the screening programme at least once (57.6%), the prevalence of cervical dysplasia was 5.1%. No cases of neoplasia were found. In the simple logistic regression analysis, there was no association between attending the screening programme and any variable. The study also showed no association between the variables collected and the presence of infection and dysplasia. These results are influenced by the absence of screening data in a significant percentage of patients and by the low prevalence of dysplasia found in this series of patients with rheumatic diseases. Las pacientes con enfermedades reumatológicas presentan un estado de inmunosupresión por la enfermedad de base y los tratamientos utilizados, lo cual es un factor de riesgo para desarrollar neoplasia de cérvix uterino. Uno de los principales factores de riesgo consiste en no acudir al programa de detección precoz del virus del papiloma humano. Los objetivos de este trabajo fueron evaluar la adherencia al programa de cribado de pacientes seguidas en consultas externas de reumatología, así como estudiar la prevalencia de lesiones cervicales y su asociación con distintos aspectos de la enfermedad y los tratamientos recibidos. Estudio retrospectivo en el que se revisaron las historias clínicas electrónicas de pacientes con seguimiento activo en un hospital terciario con artritis reumatoide (AR), artritis psoriásica (APS) y lupus eritematoso sistémico (LES). Se incluyó 307 pacientes. No se hallaron datos de asistencia al c
doi_str_mv 10.1016/j.reumae.2020.05.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2596011400</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S217357432100071X</els_id><sourcerecordid>2596011400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1569-8da86c29a0a543c0f81c51a95cd997906f0c8dc1dec9842f017ce2cc736d5b873</originalsourceid><addsrcrecordid>eNp9Uctu1TAUtBCIVm3_oEJesuCG4ySOYxZIqAKKVKkburZc-4TrqyQOflzpfkj_F0cpjxXe2BrNnPGcIeSaQcWAde8PVcA8aaxqqKECXgGIF-S8ZqLZcdE2L_95n5GrGA9QTl9z2YnX5KxpBe8akOfk6baMmemiFzeOftL06EKONJqAOLv5xweKRz1mnZyfqR9owpgKTPVsaczhiEWmZ4PUzTTs1z8l7yzVIe2DSy6-o0v0wRW9-Qtu6lNMOBV4zEtxxHBKe1zlMcdL8mrQY8Sr5_uCPHz5_P3mdnd3__Xbzae7nWG8k7ve6r4ztdSgedsYGHpmONOSGyulkNANYHprmEUj-7YegAmDtTGi6Sx_7EVzQd5uc5fgf-YSTU0uGlwjoc9RrfsCxlqAQm03qgk-xoCDWoKbdDgpBmrtRB3U1olaO1HAVemkyN48O-THCe0f0e8GCuHjRsCS8-gwqGgclo1aF9AkZb37v8MvYPGjmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2596011400</pqid></control><display><type>article</type><title>Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Vidal Alejandre, Blanca ; Tovar Sugrañes, Ernesto ; López Poza, Raquel ; Andrés, Mariano ; Martínez-Vidal, María Paz</creator><creatorcontrib>Vidal Alejandre, Blanca ; Tovar Sugrañes, Ernesto ; López Poza, Raquel ; Andrés, Mariano ; Martínez-Vidal, María Paz</creatorcontrib><description>Immunosuppression is a known risk factor for cervical cancer. Women with rheumatic conditions are immunosuppressed due to the disease and the treatments. One of the main risk factors for this neoplasm is the lack of adherence to early detection programmes for human papillomavirus. The objectives of this study were to evaluate the adherence to the screening programme of patients in the Rheumatology Clinic, as well as to evaluate the prevalence of cervical lesions and their association with the different disease characteristics and the treatments received. A descriptive retrospective study. The electronic medical history of patients actively being followed up in a tertiary hospital with rheumatoid arthritis (RA), psoriatic arthritis (PSA) and systemic lupus erythematosus (SLE) were reviewed. Finally, 307 patients were included. No data were found for screening programme attendance in up to 42.4% of the patients (39.6% in RA, 43.8% in PSA and 46% in SLE). Among the patients who attended the screening programme at least once (57.6%), the prevalence of cervical dysplasia was 5.1%. No cases of neoplasia were found. In the simple logistic regression analysis, there was no association between attending the screening programme and any variable. The study also showed no association between the variables collected and the presence of infection and dysplasia. These results are influenced by the absence of screening data in a significant percentage of patients and by the low prevalence of dysplasia found in this series of patients with rheumatic diseases. Las pacientes con enfermedades reumatológicas presentan un estado de inmunosupresión por la enfermedad de base y los tratamientos utilizados, lo cual es un factor de riesgo para desarrollar neoplasia de cérvix uterino. Uno de los principales factores de riesgo consiste en no acudir al programa de detección precoz del virus del papiloma humano. Los objetivos de este trabajo fueron evaluar la adherencia al programa de cribado de pacientes seguidas en consultas externas de reumatología, así como estudiar la prevalencia de lesiones cervicales y su asociación con distintos aspectos de la enfermedad y los tratamientos recibidos. Estudio retrospectivo en el que se revisaron las historias clínicas electrónicas de pacientes con seguimiento activo en un hospital terciario con artritis reumatoide (AR), artritis psoriásica (APS) y lupus eritematoso sistémico (LES). Se incluyó 307 pacientes. No se hallaron datos de asistencia al cribado en 42,4% (39,6% en AR, 43,8% en APS y 46% en LES). Entre las pacientes que asistieron al menos una vez (57,6%), la prevalencia de displasia de cérvix fue del 5,1%. No se encontró ningún caso de neoplasia. En el análisis de regresión logística simple no se encontró asociación entre las variables recogidas y la presencia de infección y displasia. Es remarcable la ausencia de datos de asistencia al cribado de cáncer de cérvix en un porcentaje considerable de las pacientes con enfermedades reumáticas, lo cual dificulta el estudio del papel de la enfermedad y su tratamiento.</description><identifier>ISSN: 2173-5743</identifier><identifier>EISSN: 2173-5743</identifier><identifier>DOI: 10.1016/j.reumae.2020.05.007</identifier><identifier>PMID: 34756309</identifier><language>eng</language><publisher>Spain: Elsevier España, S.L.U</publisher><subject>Alphapapillomavirus ; Arthritis, Psoriatic - diagnosis ; Arthritis, Rheumatoid ; Artritis psoriásica ; Artritis reumatoide ; Cervical neoplasia ; Cribado ; Displasia ; Dysplasia ; Female ; Humans ; Lupus eritematoso sistémico ; Lupus Erythematosus, Systemic - diagnosis ; Neoplasia de cérvix ; Psoriatic arthritis ; Retrospective Studies ; Rheumatoid arthritis ; Screening ; Systemic lupus erythematosus</subject><ispartof>Reumatología clinica (Barcelona), 2021-11, Vol.17 (9), p.494-498</ispartof><rights>2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología</rights><rights>Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1569-8da86c29a0a543c0f81c51a95cd997906f0c8dc1dec9842f017ce2cc736d5b873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34756309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vidal Alejandre, Blanca</creatorcontrib><creatorcontrib>Tovar Sugrañes, Ernesto</creatorcontrib><creatorcontrib>López Poza, Raquel</creatorcontrib><creatorcontrib>Andrés, Mariano</creatorcontrib><creatorcontrib>Martínez-Vidal, María Paz</creatorcontrib><title>Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus</title><title>Reumatología clinica (Barcelona)</title><addtitle>Reumatol Clin (Engl Ed)</addtitle><description>Immunosuppression is a known risk factor for cervical cancer. Women with rheumatic conditions are immunosuppressed due to the disease and the treatments. One of the main risk factors for this neoplasm is the lack of adherence to early detection programmes for human papillomavirus. The objectives of this study were to evaluate the adherence to the screening programme of patients in the Rheumatology Clinic, as well as to evaluate the prevalence of cervical lesions and their association with the different disease characteristics and the treatments received. A descriptive retrospective study. The electronic medical history of patients actively being followed up in a tertiary hospital with rheumatoid arthritis (RA), psoriatic arthritis (PSA) and systemic lupus erythematosus (SLE) were reviewed. Finally, 307 patients were included. No data were found for screening programme attendance in up to 42.4% of the patients (39.6% in RA, 43.8% in PSA and 46% in SLE). Among the patients who attended the screening programme at least once (57.6%), the prevalence of cervical dysplasia was 5.1%. No cases of neoplasia were found. In the simple logistic regression analysis, there was no association between attending the screening programme and any variable. The study also showed no association between the variables collected and the presence of infection and dysplasia. These results are influenced by the absence of screening data in a significant percentage of patients and by the low prevalence of dysplasia found in this series of patients with rheumatic diseases. Las pacientes con enfermedades reumatológicas presentan un estado de inmunosupresión por la enfermedad de base y los tratamientos utilizados, lo cual es un factor de riesgo para desarrollar neoplasia de cérvix uterino. Uno de los principales factores de riesgo consiste en no acudir al programa de detección precoz del virus del papiloma humano. Los objetivos de este trabajo fueron evaluar la adherencia al programa de cribado de pacientes seguidas en consultas externas de reumatología, así como estudiar la prevalencia de lesiones cervicales y su asociación con distintos aspectos de la enfermedad y los tratamientos recibidos. Estudio retrospectivo en el que se revisaron las historias clínicas electrónicas de pacientes con seguimiento activo en un hospital terciario con artritis reumatoide (AR), artritis psoriásica (APS) y lupus eritematoso sistémico (LES). Se incluyó 307 pacientes. No se hallaron datos de asistencia al cribado en 42,4% (39,6% en AR, 43,8% en APS y 46% en LES). Entre las pacientes que asistieron al menos una vez (57,6%), la prevalencia de displasia de cérvix fue del 5,1%. No se encontró ningún caso de neoplasia. En el análisis de regresión logística simple no se encontró asociación entre las variables recogidas y la presencia de infección y displasia. Es remarcable la ausencia de datos de asistencia al cribado de cáncer de cérvix en un porcentaje considerable de las pacientes con enfermedades reumáticas, lo cual dificulta el estudio del papel de la enfermedad y su tratamiento.</description><subject>Alphapapillomavirus</subject><subject>Arthritis, Psoriatic - diagnosis</subject><subject>Arthritis, Rheumatoid</subject><subject>Artritis psoriásica</subject><subject>Artritis reumatoide</subject><subject>Cervical neoplasia</subject><subject>Cribado</subject><subject>Displasia</subject><subject>Dysplasia</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus eritematoso sistémico</subject><subject>Lupus Erythematosus, Systemic - diagnosis</subject><subject>Neoplasia de cérvix</subject><subject>Psoriatic arthritis</subject><subject>Retrospective Studies</subject><subject>Rheumatoid arthritis</subject><subject>Screening</subject><subject>Systemic lupus erythematosus</subject><issn>2173-5743</issn><issn>2173-5743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uctu1TAUtBCIVm3_oEJesuCG4ySOYxZIqAKKVKkburZc-4TrqyQOflzpfkj_F0cpjxXe2BrNnPGcIeSaQcWAde8PVcA8aaxqqKECXgGIF-S8ZqLZcdE2L_95n5GrGA9QTl9z2YnX5KxpBe8akOfk6baMmemiFzeOftL06EKONJqAOLv5xweKRz1mnZyfqR9owpgKTPVsaczhiEWmZ4PUzTTs1z8l7yzVIe2DSy6-o0v0wRW9-Qtu6lNMOBV4zEtxxHBKe1zlMcdL8mrQY8Sr5_uCPHz5_P3mdnd3__Xbzae7nWG8k7ve6r4ztdSgedsYGHpmONOSGyulkNANYHprmEUj-7YegAmDtTGi6Sx_7EVzQd5uc5fgf-YSTU0uGlwjoc9RrfsCxlqAQm03qgk-xoCDWoKbdDgpBmrtRB3U1olaO1HAVemkyN48O-THCe0f0e8GCuHjRsCS8-gwqGgclo1aF9AkZb37v8MvYPGjmg</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Vidal Alejandre, Blanca</creator><creator>Tovar Sugrañes, Ernesto</creator><creator>López Poza, Raquel</creator><creator>Andrés, Mariano</creator><creator>Martínez-Vidal, María Paz</creator><general>Elsevier España, S.L.U</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202111</creationdate><title>Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus</title><author>Vidal Alejandre, Blanca ; Tovar Sugrañes, Ernesto ; López Poza, Raquel ; Andrés, Mariano ; Martínez-Vidal, María Paz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1569-8da86c29a0a543c0f81c51a95cd997906f0c8dc1dec9842f017ce2cc736d5b873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alphapapillomavirus</topic><topic>Arthritis, Psoriatic - diagnosis</topic><topic>Arthritis, Rheumatoid</topic><topic>Artritis psoriásica</topic><topic>Artritis reumatoide</topic><topic>Cervical neoplasia</topic><topic>Cribado</topic><topic>Displasia</topic><topic>Dysplasia</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus eritematoso sistémico</topic><topic>Lupus Erythematosus, Systemic - diagnosis</topic><topic>Neoplasia de cérvix</topic><topic>Psoriatic arthritis</topic><topic>Retrospective Studies</topic><topic>Rheumatoid arthritis</topic><topic>Screening</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vidal Alejandre, Blanca</creatorcontrib><creatorcontrib>Tovar Sugrañes, Ernesto</creatorcontrib><creatorcontrib>López Poza, Raquel</creatorcontrib><creatorcontrib>Andrés, Mariano</creatorcontrib><creatorcontrib>Martínez-Vidal, María Paz</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Reumatología clinica (Barcelona)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vidal Alejandre, Blanca</au><au>Tovar Sugrañes, Ernesto</au><au>López Poza, Raquel</au><au>Andrés, Mariano</au><au>Martínez-Vidal, María Paz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus</atitle><jtitle>Reumatología clinica (Barcelona)</jtitle><addtitle>Reumatol Clin (Engl Ed)</addtitle><date>2021-11</date><risdate>2021</risdate><volume>17</volume><issue>9</issue><spage>494</spage><epage>498</epage><pages>494-498</pages><issn>2173-5743</issn><eissn>2173-5743</eissn><abstract>Immunosuppression is a known risk factor for cervical cancer. Women with rheumatic conditions are immunosuppressed due to the disease and the treatments. One of the main risk factors for this neoplasm is the lack of adherence to early detection programmes for human papillomavirus. The objectives of this study were to evaluate the adherence to the screening programme of patients in the Rheumatology Clinic, as well as to evaluate the prevalence of cervical lesions and their association with the different disease characteristics and the treatments received. A descriptive retrospective study. The electronic medical history of patients actively being followed up in a tertiary hospital with rheumatoid arthritis (RA), psoriatic arthritis (PSA) and systemic lupus erythematosus (SLE) were reviewed. Finally, 307 patients were included. No data were found for screening programme attendance in up to 42.4% of the patients (39.6% in RA, 43.8% in PSA and 46% in SLE). Among the patients who attended the screening programme at least once (57.6%), the prevalence of cervical dysplasia was 5.1%. No cases of neoplasia were found. In the simple logistic regression analysis, there was no association between attending the screening programme and any variable. The study also showed no association between the variables collected and the presence of infection and dysplasia. These results are influenced by the absence of screening data in a significant percentage of patients and by the low prevalence of dysplasia found in this series of patients with rheumatic diseases. Las pacientes con enfermedades reumatológicas presentan un estado de inmunosupresión por la enfermedad de base y los tratamientos utilizados, lo cual es un factor de riesgo para desarrollar neoplasia de cérvix uterino. Uno de los principales factores de riesgo consiste en no acudir al programa de detección precoz del virus del papiloma humano. Los objetivos de este trabajo fueron evaluar la adherencia al programa de cribado de pacientes seguidas en consultas externas de reumatología, así como estudiar la prevalencia de lesiones cervicales y su asociación con distintos aspectos de la enfermedad y los tratamientos recibidos. Estudio retrospectivo en el que se revisaron las historias clínicas electrónicas de pacientes con seguimiento activo en un hospital terciario con artritis reumatoide (AR), artritis psoriásica (APS) y lupus eritematoso sistémico (LES). Se incluyó 307 pacientes. No se hallaron datos de asistencia al cribado en 42,4% (39,6% en AR, 43,8% en APS y 46% en LES). Entre las pacientes que asistieron al menos una vez (57,6%), la prevalencia de displasia de cérvix fue del 5,1%. No se encontró ningún caso de neoplasia. En el análisis de regresión logística simple no se encontró asociación entre las variables recogidas y la presencia de infección y displasia. Es remarcable la ausencia de datos de asistencia al cribado de cáncer de cérvix en un porcentaje considerable de las pacientes con enfermedades reumáticas, lo cual dificulta el estudio del papel de la enfermedad y su tratamiento.</abstract><cop>Spain</cop><pub>Elsevier España, S.L.U</pub><pmid>34756309</pmid><doi>10.1016/j.reumae.2020.05.007</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2173-5743
ispartof Reumatología clinica (Barcelona), 2021-11, Vol.17 (9), p.494-498
issn 2173-5743
2173-5743
language eng
recordid cdi_proquest_miscellaneous_2596011400
source MEDLINE; Alma/SFX Local Collection
subjects Alphapapillomavirus
Arthritis, Psoriatic - diagnosis
Arthritis, Rheumatoid
Artritis psoriásica
Artritis reumatoide
Cervical neoplasia
Cribado
Displasia
Dysplasia
Female
Humans
Lupus eritematoso sistémico
Lupus Erythematosus, Systemic - diagnosis
Neoplasia de cérvix
Psoriatic arthritis
Retrospective Studies
Rheumatoid arthritis
Screening
Systemic lupus erythematosus
title Human papilloma virus screening: evaluation of testing and surveillance in rheumatoid arthritis, psoriatic arthritis and systemic lupus erythematosus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T03%3A14%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20papilloma%20virus%20screening:%20evaluation%20of%20testing%20and%20surveillance%20in%20rheumatoid%20arthritis,%20psoriatic%20arthritis%20and%20systemic%20lupus%20erythematosus&rft.jtitle=Reumatolog%C3%ADa%20clinica%20(Barcelona)&rft.au=Vidal%20Alejandre,%20Blanca&rft.date=2021-11&rft.volume=17&rft.issue=9&rft.spage=494&rft.epage=498&rft.pages=494-498&rft.issn=2173-5743&rft.eissn=2173-5743&rft_id=info:doi/10.1016/j.reumae.2020.05.007&rft_dat=%3Cproquest_cross%3E2596011400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2596011400&rft_id=info:pmid/34756309&rft_els_id=S217357432100071X&rfr_iscdi=true